177 related articles for article (PubMed ID: 29895198)
1. Long non-coding RNA GAS5 sensitizes renal cell carcinoma to sorafenib via miR-21/SOX5 pathway.
Liu L; Pang X; Shang W; Xie H; Feng Y; Feng G
Cell Cycle; 2019 Feb; 18(3):257-263. PubMed ID: 29895198
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA-SRLR elicits intrinsic sorafenib resistance via evoking IL-6/STAT3 axis in renal cell carcinoma.
Xu Z; Yang F; Wei D; Liu B; Chen C; Bao Y; Wu Z; Wu D; Tan H; Li J; Wang J; Liu J; Sun S; Qu L; Wang L
Oncogene; 2017 Apr; 36(14):1965-1977. PubMed ID: 27841868
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicles transmitted miR-31-5p promotes sorafenib resistance by targeting MLH1 in renal cell carcinoma.
He J; He J; Min L; He Y; Guan H; Wang J; Peng X
Int J Cancer; 2020 Feb; 146(4):1052-1063. PubMed ID: 31259424
[TBL] [Abstract][Full Text] [Related]
4. MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib.
Zheng B; Zhu H; Gu D; Pan X; Qian L; Xue B; Yang D; Zhou J; Shan Y
Biochem Biophys Res Commun; 2015 Apr; 459(2):234-239. PubMed ID: 25712526
[TBL] [Abstract][Full Text] [Related]
5. Long non‑coding RNA PLK1S1 was associated with renal cell carcinoma progression by interacting with microRNA‑653 and altering C‑X‑C chemokine receptor 5 expression.
Li W; Yang D; Zhang Y; Zhao S; Li D; Liu M
Oncol Rep; 2020 Nov; 44(5):1985-1996. PubMed ID: 33000253
[TBL] [Abstract][Full Text] [Related]
6. Dual biomarkers long non-coding RNA GAS5 and microRNA-34a co-expression signature in common solid tumors.
Toraih EA; Alghamdi SA; El-Wazir A; Hosny MM; Hussein MH; Khashana MS; Fawzy MS
PLoS One; 2018; 13(10):e0198231. PubMed ID: 30289954
[TBL] [Abstract][Full Text] [Related]
7. LncRNA POU3F3 Promotes Cancer Cell Proliferation, Migration, and Invasion in Renal Cell Carcinoma by Downregulating LncRNA GAS5.
Zhang L; Wang C; Ma M
Kidney Blood Press Res; 2021; 46(5):613-619. PubMed ID: 34352801
[TBL] [Abstract][Full Text] [Related]
8. New frontiers against sorafenib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers.
He Y; Luo Y; Huang L; Zhang D; Wang X; Ji J; Liang S
Pharmacol Res; 2021 Aug; 170():105732. PubMed ID: 34139345
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma.
Qiao HP; Gao WS; Huo JX; Yang ZS
Asian Pac J Cancer Prev; 2013; 14(2):1077-82. PubMed ID: 23621190
[TBL] [Abstract][Full Text] [Related]
10. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
Wang Z; Chang X; Zhu G; Gao X; Chang L
Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095
[TBL] [Abstract][Full Text] [Related]
11. Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA.
Qu L; Ding J; Chen C; Wu ZJ; Liu B; Gao Y; Chen W; Liu F; Sun W; Li XF; Wang X; Wang Y; Xu ZY; Gao L; Yang Q; Xu B; Li YM; Fang ZY; Xu ZP; Bao Y; Wu DS; Miao X; Sun HY; Sun YH; Wang HY; Wang LH
Cancer Cell; 2016 May; 29(5):653-668. PubMed ID: 27117758
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-like protein 3 blocks nuclear import of FAK and contributes to sorafenib response.
Bao Y; Yang F; Liu B; Zhao T; Xu Z; Xiong Y; Sun S; Qu L; Wang L
Br J Cancer; 2018 Aug; 119(4):450-461. PubMed ID: 30033448
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma.
Liu Y; Cheng G; Huang Z; Bao L; Liu J; Wang C; Xiong Z; Zhou L; Xu T; Liu D; Yang H; Chen K; Zhang X
Cell Death Dis; 2020 Jul; 11(7):515. PubMed ID: 32641718
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HOTAIR regulates HIF-1α/AXL signaling through inhibition of miR-217 in renal cell carcinoma.
Hong Q; Li O; Zheng W; Xiao WZ; Zhang L; Wu D; Cai GY; He JC; Chen XM
Cell Death Dis; 2017 May; 8(5):e2772. PubMed ID: 28492542
[TBL] [Abstract][Full Text] [Related]
15. RASSF6-mediated inhibition of Mcl-1 through JNK activation improves the anti-tumor effects of sorafenib in renal cell carcinoma.
Liang YY; Deng XB; Zeng LS; Lin XT; Shao XF; Wang B; Mo ZW; Yuan YW
Cancer Lett; 2018 Sep; 432():75-83. PubMed ID: 29864454
[TBL] [Abstract][Full Text] [Related]
16. Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib.
Faranda T; Grossi I; Manganelli M; Marchina E; Baiocchi G; Portolani N; Crosatti M; De Petro G; Salvi A
Sci Rep; 2019 Jun; 9(1):9118. PubMed ID: 31235746
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNA MALAT1 Contributes to Sorafenib Resistance by Targeting miR-140-5p/Aurora-A Signaling in Hepatocellular Carcinoma.
Fan L; Huang X; Chen J; Zhang K; Gu YH; Sun J; Cui SY
Mol Cancer Ther; 2020 May; 19(5):1197-1209. PubMed ID: 32220970
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA Small Nucleolar RNA Host Gene 1 (SNHG1) Promotes Renal Cell Carcinoma Progression and Metastasis by Negatively Regulating miR-137.
Zhao S; Wang Y; Luo M; Cui W; Zhou X; Miao L
Med Sci Monit; 2018 Jun; 24():3824-3831. PubMed ID: 29874202
[TBL] [Abstract][Full Text] [Related]
19. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
Wu C; Zhang J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
[TBL] [Abstract][Full Text] [Related]
20. TOPK/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC.
Sun H; Zheng J; Xiao J; Yue J; Shi Z; Xuan Z; Chen C; Zhao Y; Tang W; Ye S; Li J; Deng Q; Zhang L; Zhu F; Shao C
Cell Death Dis; 2022 May; 13(5):450. PubMed ID: 35546143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
